Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals
Lucia Taramasso(Ospedale Policlinico San Martino), Antonio Di Biagio, Paolo Maggi(Università degli Studi di Enna Kore), Chiara Dentone(Ospedale di Sanremo), Benedetto Maurizio Celesia(Ospedale Garibaldi), Giancarlo Orofino(Ospedale Amedeo di Savoia), Giuseppe Vittorio De Socio(University of Perugia), Elena Ricci(Mario Negri Institute for Pharmacological Research), Canio Martinelli(Azienda Ospedaliero-Universitaria Careggi), Barbara Menzaghi(Ospedale di Circolo di Busto Arsizio), Marco Franzetti, Giordano Madeddu(University of Sassari), Paolo Bonfanti(University of California San Diego), Simone Passerini(Office of Infectious Diseases), Giovanni Penco(Ente Ospedaliero Ospedali Galliera), Raffaella Libertone(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Tiziana Quirino(Ospedale di Circolo di Busto Arsizio)
Cited by 8
Related Papers
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
|CHEST Journal|2021|404
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels
|medRxiv|2020|234
Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program
|Clinical Infectious Diseases|2012|208